| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |